New developments in medical science and its treatments and advances in research are giving new hope to people affected by Osteoarthritis pain and symptoms. Stem cell therapy for Osteoarthritis is being studied for efficacy in improving the complications in patients through the use of their own stem cells. This may help patients who don’t respond to typical drug treatment, want to reduce their reliance on medication, or are looking to try stem cell therapy before starting drug treatment.

the deterioration of cartilage that cushions the ends of bones in your joints is the major of complication in Osteoarthritis patients are facing.The Cartilage is a firm, slippery tissue that permits nearly frictionless joint motion. In Osteoarthritis, this surface become rough. Eventually, if the cartilage wears down completely, patients will be left with bone rubbing on bone.

Mesenchymal stem cells are multipotent and have the ability to differentiate into cartilage called (chondrites). The goal of each stem cell treatment is to inject the stem cells into the joint to create cartilage (chondrite cells). More over the Stem cells are naturally anti-inflammatoriesso it can assist with Osteoarthritis pain and swelling in the joint area.

The adult stem cells used to treat osteoarthritis at the Stem Cell Institute come from human umbilical cord tissue (allogeneic mesenchymal). These stem cells are expanded at Medistem Panama’s state-of-the-art laboratory.

The mesenchymal stem cells we use are recovered from donated umbilical cords following normal, healthy births. Each mother has her medical history screened and is tested for infectious diseases. Proper consent is received from each family prior to donation.

All umbilical cord-derived stem cells are screened for infectious diseases to International Blood Bank Standards before they are cleared for use in patients.

Only a small percentage of donated umbilical cords pass our rigorous screening process.

Immune modulating capacity, and ability to stimulate regeneration can be screened and selected by the stem cells with the best anti-inflammatory activity.

Allogeneic stem cells can be handled multiple times in the course of days in uniform dosages that contain high cell counts.An abundant supply of mesenchymal stem cells are given by Umbilical cord tissue hence No need to collect stem cells from the patient’s hip bone or fat under anesthesia, which especially for small children and their parents, can be an unpleasant ordeal.

There is a clear evidence showing that umbilical cord-derived mesenchymal stem cells through growing body so they are more robust than mesenchymal stem cells from other sources. Since there isno need to administer chemotherapy drugs like Granulocyte-colony stimulating factor (G-CSF or GCSF) to stimulate the bone marrow to produce granulocytes and stem cells and release them into the bloodstream.

Treatment protocol will be assigned by staff physicians after the patient has submitted all requested medical information and received approval. A patient’s recommended protocol may differ from the example given below.

Treatment duration: 4 days and 5 nights. Physical examination and blood testing: Monday 5 IV injections of expanded allogeneic (low-passage) mesenchymal stem cells